Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer

Roberge, Guillaume; Delluc, Aurélien

doi:10.1016/j.thromres.2020.10.033

Cited by 2 publications

(1 citation statement)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Subsegmental pulmonary embolus (SSPE) is another entity that is more commonly detected, given the improvements in radiographic imaging. SSPE poses a particular treatment challenge as the clinical significance of SSPE, especially in a single SSPE in the absence of concomitant DVT, is not well characterized [ 32 ]. In a subgroup analysis of an international prospective cohort study involving patients with cancer and incidental PE, SSPEs and more proximal PEs had a similar 12-month recurrence rate of VTE (6.4% and 6.0%, respectively) [ 33 ].…”

Section: Important Considerations When Choosing An Anticoagulation Tr...mentioning

confidence: 99%

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner

2022

View full text Add to dashboard Cite

Cancer-associated venous thromboembolism is a devastating complication of cancer and is associated with significant morbidity and mortality. The cornerstone of cancer-associated venous thromboembolism treatment is anticoagulation, and in recent years, there have been notable randomized clinical trials that have revealed insights into the efficacy and safety of direct oral anticoagulants and low-molecular-weight heparin in the treatment of cancer-associated thrombosis. Deciding on the ideal anticoagulation treatment plan for a patient with a cancer-associated thrombosis is a complex task that requires an understanding of clinical trial data, society guidelines, and, most importantly, consideration of many cancer-related, treatment-related, and patient-related factors. This article summarizes important factors to consider when deciding on anticoagulation therapy for a patient with cancer-associated thrombosis.

show abstract

Section: Important Considerations When Choosing An Anticoagulation Tr...mentioning

confidence: 99%

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner

2022

View full text Add to dashboard Cite

show abstract

Special series on challenging anticoagulation cases: Experience counts when guidelines fall short

Bates

Klok²

2021

Thrombosis Research

View full text Add to dashboard Cite

Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer

Cited by 2 publications

References 72 publications

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner

Practical Considerations for the Management of Cancer-Associated Venous Thromboembolism: A Guide for the General Oncology Practitioner

Special series on challenging anticoagulation cases: Experience counts when guidelines fall short

Contact Info

Product

Resources

About